GlassScriptPhysician profile
Dawn J Jones
NPI 1174852925
$4,907.07
in general payments reported to CMS, 2019-2025
25 companies · $400 in 2025
The $400 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $184 · 2021: $295 · 2022: $3,168 · 2023: $377 · 2024: $313 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.86 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,028.98 | 2021-2022 | |
| Abbvie INC. | $487.84 | 2019-2025 | |
| Daiichi Sankyo INC. | $246.60 | 2024-2025 | Injectafer |
| Astellas Pharma US INC | $137.25 | 2023-2024 | Veozah |
| Optumhealth Care Solutions, LLC | $128.67 | 2023-2025 | Vivify Health Care Team Portal, Zyno Solutions, Eitan Medical |
| Aspira Women'S Health INC | $103.38 | 2022-2025 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $101.96 | 2024-2025 | |
| Hologic Sales and Service, LLC | $101.78 | 2019-2025 | Aptima, Myosure Tissue Removal Device |
| Mylan Pharmaceuticals INC. | $95.90 | 2020-2022 | |
| Evofem Biosciences, INC. | $66.46 | 2020-2023 | Phexxi |
| Pfizer INC. | $66.28 | 2023-2024 | |
| Coopersurgical, INC. | $58.84 | 2021-2023 | Paragard T 380a |
| Janssen Biotech, INC. | $39.61 | 2023 | |
| Minerva Surgical, INC | $36.57 | 2021 | |
| Sumitomo Pharma America, INC. | $34.72 | 2024 | Myfembree |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $24.33 | 2020 | |
| Novo Nordisk INC | $23.30 | 2025 | Ozempic |
| Amgen INC. | $18.77 | 2019 | |
| Exact Sciences Corporation | $16.96 | 2025 | The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $16.41 | 2021 | |
| Medline Industries LP | $16.01 | 2019 | |
| Sage Therapeutics, LLC | $14.64 | 2019 | |
| Becton, Dickinson and Company | $14.39 | 2023 | Bd Onclarity |
| Biogen, INC. | $14.15 | 2024 | |
| Lupin INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.